Corporate ActionMay 6, 2026, 11:02 PM
Cytokinetics Prices Public Offering of 9.86M Shares at $71, Raising ~$700M
AI Summary
Cytokinetics, Incorporated announced the pricing of an underwritten public offering of 9,859,155 shares of its common stock at $71.00 per share. The offering is expected to generate approximately $700 million in gross proceeds for the company, before deducting underwriting discounts and other expenses. The offering is anticipated to close on May 8, 2026, and includes a 30-day option for underwriters to purchase up to an additional 1,478,873 shares.
Key Highlights
- Cytokinetics priced an underwritten public offering of 9,859,155 shares of common stock.
- The shares were priced at $71.00 per share.
- Gross proceeds are expected to be approximately $700 million.
- Underwriters have a 30-day option to purchase up to an additional 1,478,873 shares.
- The offering is expected to close on May 8, 2026.
- All shares in the offering will be sold by Cytokinetics.
Price Impact
More from CYTK